Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Medical Hypotheses|July 18, 2006
Statins may decrease skeletal-related events in breast cancer patients with bone metastasesMurat Dincer, Nilufer Bulut, Hakan Harputluoglu, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 4, 2006
Synchronous presentation of nasopharyngeal and renal cell carcinomasCem Boruban, Ozlem Yavas, Kadri Altundag, et al.
Current Medical Research and Opinion|May 23, 2013
Cardiotoxicity of novel HER2-targeted therapiesMehmet A N Sendur, Sercan Aksoy, Kadri Altundag
Medical Oncology (Northwood, London, England)|May 3, 2013
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metforminSercan Aksoy, Mehmet Ali Nahit Sendur, Kadri Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitorsSerkan Akin, Taner Babacan, Furkan Sarici, et al.
Expert Opinion on Therapeutic Targets|November 26, 2010
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literatureCagatay Arslan, Ebru Sari, Sercan Aksoy, et al.
Medical Hypotheses|July 9, 2004
Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenesOzden Altundag, Kadri Altundag, Paolo Morandi, et al.
Medical Hypotheses|October 19, 2004
Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifenKadri Altundag, Ozden Altundag, Mehmet Gunduz, et al.
Current Medical Research and Opinion|September 8, 2012
Pertuzumab in HER2-positive breast cancerMehmet A N Sendur, Sercan Aksoy, Kadri Altundag
Medical Oncology (Northwood, London, England)|May 20, 2008
A case report: zoledronic acid-induced anterior uveitisSaadettin Kilickap, Yasemin Ozdamar, M Kadri Altundag, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Medical Hypotheses|July 18, 2006
Statins may decrease skeletal-related events in breast cancer patients with bone metastasesMurat Dincer, Nilufer Bulut, Hakan Harputluoglu, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 4, 2006
Synchronous presentation of nasopharyngeal and renal cell carcinomasCem Boruban, Ozlem Yavas, Kadri Altundag, et al.
Current Medical Research and Opinion|May 23, 2013
Cardiotoxicity of novel HER2-targeted therapiesMehmet A N Sendur, Sercan Aksoy, Kadri Altundag
Medical Oncology (Northwood, London, England)|May 3, 2013
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metforminSercan Aksoy, Mehmet Ali Nahit Sendur, Kadri Altundag
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitorsSerkan Akin, Taner Babacan, Furkan Sarici, et al.
Expert Opinion on Therapeutic Targets|November 26, 2010
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literatureCagatay Arslan, Ebru Sari, Sercan Aksoy, et al.
Medical Hypotheses|July 9, 2004
Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenesOzden Altundag, Kadri Altundag, Paolo Morandi, et al.
Medical Hypotheses|October 19, 2004
Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifenKadri Altundag, Ozden Altundag, Mehmet Gunduz, et al.
Current Medical Research and Opinion|September 8, 2012
Pertuzumab in HER2-positive breast cancerMehmet A N Sendur, Sercan Aksoy, Kadri Altundag
Medical Oncology (Northwood, London, England)|May 20, 2008
A case report: zoledronic acid-induced anterior uveitisSaadettin Kilickap, Yasemin Ozdamar, M Kadri Altundag, et al.
Pageof 16